Cervical cancer shots less cost-effective with age
August 20, 2008 By MIKE STOBBE , AP Medical Writer(AP) -- An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
Similar stories from PHYSorg:
Cost-effectiveness of HPV vaccination in the Netherlands
Jul 01, 2009 |
not rated yet |
0
One in four California adolescent girls has had HPV vaccine
Feb 17, 2009 |
not rated yet |
0
Panel backs vaccine as cervical cancer alternative
Oct 21, 2009 |
not rated yet |
0
WHO approves cervical cancer vaccine Cervarix
Jul 09, 2009 |
1 / 5 (1) |
0
Cervical cancer prevention should focus on vaccinating adolescent girls
Aug 21, 2008 |
5 / 5 (1) |
0
Display comments: newest first
-
sheber - Aug 21, 2008
- Rank: not rated yet
It also assumes that it isn't going to be pulled off the market for causing more harm than good after it's too late for all the girls who took it before their child bearing years!- report abuse
